.Attributes Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective calls for incorporation of patients along with MASLD and also size of liver end results in cardio-- kidney-- metabolic trials, when information advise mechanistically tenable benefits and scientific safety-- and details factors for test style and also governing approval.